Stat1 and Stat2 but Not Stat3 Arbitrate Contradictory Growth Signals Elicited by Alpha/Beta Interferon in T Lymphocytes

REFERENCES

• Biron, C. A. 2001. Interferons alpha and beta as immune regulators—a new look. Immunity 14:661–664.
   PubMed Web of Science ®Google Scholar
• Cantrell, D. A. 2003. Regulation and function of serine kinase networks in lymphocytes. Curr. Opin. Immunol. 15:294–298.
   PubMedGoogle Scholar
• Costa-Pereira, A. P., S. Tininini, B. Strobl, T. Alonzi, J. F. Schlaak, H. Is'harc, I. Gesualdo, S. J. Newman, I. M. Kerr, and V. Poli. 2002. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc. Natl. Acad. Sci. USA 99:8043–8047.
   PubMed Web of Science ®Google Scholar
• Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148.
   PubMed Web of Science ®Google Scholar
• Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, A. Al Ghonaium, H. Tufenkeji, H. Frayha, S. Al-Gazlan, H. Al-Rayes, R. D. Schreiber, I. Gresser, and J. L. Casanova. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388–391.
   PubMed Web of Science ®Google Scholar
• Durbin, J. E., A. Fernandez-Sesma, C.-K. Lee, T. D. Rao, A. B. Frey, T. M. Moran, S. Vukmanovic, A. García-Sastre, and D. E. Levy. 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164:4220–4228.
   PubMed Web of Science ®Google Scholar
• Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443–450.
   PubMed Web of Science ®Google Scholar
• Gongora, R., R. P. Stephan, R. D. Schreiber, and M. D. Cooper. 2000. Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs. J. Immunol. 165:2362–2366.
   PubMedGoogle Scholar
• Hatakeyama, M., and R. A. Weinberg. 1995. The role of RB in cell cycle control. Prog. Cell Cycle Res. 1:9–19.
   PubMedGoogle Scholar
• Horvath, C. M. 2004. Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev. 15:117–127.
   PubMedGoogle Scholar
• Horvath, C. M., and J. E. Darnell. 1996. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J. Virol. 70:647–650.
   PubMed Web of Science ®Google Scholar
• Ivashkiv, L. B. 2003. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity 36:473–479.
   PubMed Web of Science ®Google Scholar
• Iwase, S., Y. Furukawa, J. Kikuchi, M. Nagai, Y. Terui, M. Nakamura, and H. Yamada. 1997. Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J. Biol. Chem. 272:12406–12414.
   PubMed Web of Science ®Google Scholar
• Kumagai, N., S. H. Benedict, G. B. Mills, and E. W. Gelfand. 1987. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes. J. Immunol. 139:1393–1399.
   PubMed Web of Science ®Google Scholar
• Lee, C.-K., R. Gimeno, and D. E. Levy. 1999. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes. J. Exp. Med. 190:1451–1463.
   PubMedGoogle Scholar
• Lee, C.-K., D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165:3571–3577.
   PubMed Web of Science ®Google Scholar
• Lee, C.-K., R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho, and D. E. Levy. 2002. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17:63–72.
   PubMed Web of Science ®Google Scholar
• Lee, C.-K., E. Smith, R. Gimeno, R. Gertner, and D. E. Levy. 2000. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J. Immunol. 164:1286–1292.
   PubMed Web of Science ®Google Scholar
• Levy, D. E. 1998. Analysis of interferon-regulated proteins binding the interferon-alpha-stimulated response element. Methods 15:167–174.
   PubMedGoogle Scholar
• Levy, D. E., and J. E. Darnell, Jr. 2002. STATs: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3:651–662.
   PubMed Web of Science ®Google Scholar
• Levy, D. E., and C.-K. Lee. 2002. What does Stat3 do. J. Clin. Investig. 109:1143–1148.
   PubMed Web of Science ®Google Scholar
• Meraz, M. A., M. J. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riely, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431–442.
   PubMed Web of Science ®Google Scholar
• Müller, U., U. Steinhoff, L. F. L. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918–1921.
   PubMed Web of Science ®Google Scholar
• Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-α/β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279–4287.
   PubMed Web of Science ®Google Scholar
• Park, C., S. Li, E. Cha, and C. Schindler. 2000. Immune response in Stat2 knockout mice. Immunity 13:795–804.
   PubMed Web of Science ®Google Scholar
• Pernis, A., S. Gupta, K. J. Gollob, E. Garfein, R. L. Coffman, C. Schindler, and P. Rothman. 1995. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 269:245–247.
   PubMed Web of Science ®Google Scholar
• Qing, Y., and G. R. Stark. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J. Biol. Chem. 279:41679–41685.
   PubMed Web of Science ®Google Scholar
• Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23:96–101.
   PubMed Web of Science ®Google Scholar
• Raz, R., J. E. Durbin, and D. E. Levy. 1994. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J. Biol. Chem. 269:24391–24395.
   PubMed Web of Science ®Google Scholar
• Raz, R., C.-K. Lee, L. A. Cannizzaro, P. d'Eustachio, and D. E. Levy. 1999. Essential role of STAT3 for embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. USA 96:2846–2851.
   PubMedGoogle Scholar
• Ronnblom, L., and G. V. Alm. 2001. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 22:427–431.
   PubMed Web of Science ®Google Scholar
• Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255–281.
   PubMed Web of Science ®Google Scholar
• Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227–264.
   PubMed Web of Science ®Google Scholar
• Tanabe, Y., T. Nishibori, L. Su, R. M. Arduini, D. P. Baker, and M. David. 2005. Role of STAT1, STAT3, and STAT5 in IFN-α/β responses in T lymphocytes. J. Immunol. 174:609–613.
   PubMedGoogle Scholar
• Tanaka, N., M. Sato, M. S. Lamphier, H. Nozawa, E. Oda, S. Noguchi, R. D. Schreiber, Y. Tsujimoto, and T. Taniguchi. 1998. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29–37.
   PubMedGoogle Scholar
• Teshigawara, K., H. M. Wang, K. Kato, and K. A. Smith. 1987. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J. Exp. Med. 165:223–238.
   PubMed Web of Science ®Google Scholar
• Tovey, M. G., M. Streuli, I. Gresser, J. Gugenheim, B. Blanchard, J. Guymarho, F. Vignaux, and M. Gigou. 1987. Interferon mRNA is produced constitutively in the organs of normal individuals. Proc. Natl. Acad. Sci. USA 84:5038–5042.
   PubMed Web of Science ®Google Scholar
• Uddin, S., F. Lekmine, A. Sassano, H. Rui, E. N. Fish, and L. C. Platanias. 2003. Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem. Biophys. Res. Commun. 308:325–330.
   PubMed Web of Science ®Google Scholar
• Wang, J., N. Pham-Mitchell, C. Schindler, and I. L. Campbell. 2003. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-α-stimulated STAT2-independent production of IFN-γ in the brain. J. Clin. Investig. 112:535–543.
   PubMedGoogle Scholar
• Wolfer, A., T. Bakker, A. Wilson, M. Nicolas, V. Ioannidis, D. R. Littman, P. P. Lee, C. B. Wilson, W. Held, H. R. MacDonald, and F. Radtke. 2001. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8 T cell development. Nat. Immunol. 2:235–241.
   PubMed Web of Science ®Google Scholar
• Zang, H., K. Sato, H. Nakajima, C. McKay, P. A. Ney, and J. N. Ihle. 2001. The distal region and receptor tyrosines of the Epo receptor are nonessential for in vivo erythropoiesis. EMBO J. 20:3156–3166.
   PubMed Web of Science ®Google Scholar